Byju’s has reportedly acquired smaller rival Scholr and the deal is likely to be announced soon. Separately, PharmEasy is in advanced talks to raise $200 million in funding from Prosus Ventures.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in